Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Augmento

K-Number: K222781 · 2023-04-11

Decision Date2023-04-11
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Augmento is the device name listed in this FDA 510(k) record. The listed applicant is Deeptek Medical Imaging Private Limited. It received FDA 510(k) clearance on 2023-04-11 under 510(k) number K222781. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Augmento?

Augmento is a medical device that received FDA 510(k) clearance on 2023-04-11. The listed applicant is Deeptek Medical Imaging Private Limited. The 510(k) number is K222781.

When did Augmento receive FDA 510(k) clearance?

Augmento received FDA 510(k) clearance on 2023-04-11, under 510(k) number K222781.

Who is the listed applicant for Augmento?

The FDA 510(k) record lists Deeptek Medical Imaging Private Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Augmento?

The FDA product code for Augmento is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.